phase readout
saveNCT06113198: A Study on the Immune Response and Safety of a Vaccine Against N. Meningitidis Serogroup B Infection in Healthy Infants From 2 Months of Age
ACTIVE_NOT_RECRUITINGupdated 2mo ago
community read0 votes
Sponsor: GlaxoSmithKline. Phase: PHASE4. Conditions: Meningitis, Meningococcal
view source ↗
comments(0)
5-min edit window · permanent after that